Literature DB >> 2084317

[The effect of various factors on the progression of kidney insufficiency cause by analgesic nephropathy].

J Kindler1, G Giani, S Handt, H G Sieberth.   

Abstract

In a retrospective study of 33 patients the influence of different anamnestic, clinical and laboratory parameters on the progression of renal failure was investigated. The analysis of progression of renal failure was evaluated in terms of a reasonable criterium intuitively suggesting itself which is based on a non-linear fitting of the serum creatinine profile. Follow-up serum creatinine levels showed that renal function became worse in 28 cases, with terminal renal failure developing in 6 cases. In 5 patients significant improvement in kidney function was observed. The variables systolic and diastolic blood pressure, total amount of ingested analgesics, continued abuse and cessation of analgesics, frequency of urinary tract infections and amount of proteinuria had no significant influence on progression of renal failure. However, a strong relationship between the initial serum creatinine level and the progression of renal failure could be established. In conclusion our results indicate that long-term prognosis of analgesic nephropathy mainly depends on early diagnosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2084317     DOI: 10.1007/BF01649301

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  24 in total

1.  Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979).

Authors:  U C Dubach; B Rosner; E Pfister
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

2.  Analgesic nephropathy: clinical syndrome and prognosis.

Authors:  R M Murray; D H Lawson; A L Linton
Journal:  Br Med J       Date:  1971-02-27

3.  Epidemiologic study of regular analgesic use and end-stage renal disease.

Authors:  T G Murray; P D Stolley; J C Anthony; R Schinnar; E Hepler-Smith; J L Jeffreys
Journal:  Arch Intern Med       Date:  1983-09

4.  Analgesic-associated nephropathy.

Authors:  A Schwarz
Journal:  Klin Wochenschr       Date:  1987-01-05

Review 5.  Clinical and pathological aspects of analgesic nephropathy.

Authors:  R S Nanra
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

6.  [Increased cardiovascular arteriosclerosis risk in patients with analgesic nephropathy (author's transl)].

Authors:  A Helber; G Wambach; W Böttcher; K Finke; R Hahn
Journal:  Dtsch Med Wochenschr       Date:  1981-10-16       Impact factor: 0.628

7.  Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

Authors:  H H Parving; A R Andersen; U M Smidt; P A Svendsen
Journal:  Lancet       Date:  1983-05-28       Impact factor: 79.321

8.  Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.

Authors:  B M Brenner
Journal:  Kidney Int       Date:  1983-04       Impact factor: 10.612

Review 9.  Renal effects of antipyretic analgesics.

Authors:  R S Nanra
Journal:  Am J Med       Date:  1983-11-14       Impact factor: 4.965

10.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.